CANbridge Pharmaceuticals Spinal Muscular Atrophy Gene Therapy Abstract Accepted for Presentation at the American Society for Gene and Cell Therapy annual Meeting

CANbridge Pharmaceuticals, Inc. announced that the American Society for Gene and Cell Therapy has accepted the following abstract for presentation at the ASCGT Annual Meeting, May 16-20, in Los Angeles, CA.